Retrospective Cohort Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Jun 28, 2015; 21(24): 7488-7494
Published online Jun 28, 2015. doi: 10.3748/wjg.v21.i24.7488
Figure 3
Figure 3 Cumulative survival according to further therapy after hepatocellular carcinoma rupture. The cumulative survival rate of patients who underwent therapy after HCC rupture was significantly increased compared with patients who did not undergo therapy after HCC rupture. The mean survival time of patients with therapy during the follow-up period was 645.5 d, whereas the mean survival time of patients without therapy was 198.6 d (P < 0.001). HCC: Hepatocellular carcinoma.